Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of Hematology

Volumn 91, Issue 8, 2012, Pages 1161-1174

  Weissinger, Florian ^a   Auner, Holger W ^b   Bertz, Hartmut ^c   Buchheidt, Dieter ^d   Cornely, Oliver A ^e   Egerer, Gerlinde ^f   Heinz, Werner ^g   Karthaus, Meinolf ^h   Kiehl, Michael ⁱ   Krüger, William ^j   Penack, Olaf ^k   Reuter, Stefan ^l   Ruhnke, Markus ^k   Sandherr, Michael ^m   Salwender, Hans Jürgen ⁿ   Ullmann, Andrew J ^o   Waldschmidt, Dirk T ^e   Wolf, Hans H ^p  

^a EVANGELISCHES KRANKENHAUS   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h Klinikum Neuperlach   (Germany)

ⁱ Klinikum Frankfurt Oder   (Germany)

^j UNIVERSITY OF GREIFSWALD   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l KLINIKUM LEVERKUSEN   (Germany)

^m Schwerpunktpraxis für Hämatologie und Onkologie   (Germany)

ⁿ ASKLEPIOS KLINIK ALTONA   (Germany)

^o JOHANNES GUTENBERG UNIVERSITY   (Germany)

^p MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

more..

Author keywords

Anti infective therapy; Autologous stem cell transplantation; Diagnostics for infection; Prophylaxis of infection; Supportive therapy for auto SCT

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; IMIPENEM; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; ANUS DISEASE; ASSISTED VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG INDICATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EUROPE; FEBRILE NEUTROPENIA; GASTROINTESTINAL INFECTION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; INFECTION COMPLICATION; INFECTION CONTROL; INFECTION RISK; KIDNEY FUNCTION; LUNG INFILTRATE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; TREATMENT DURATION; VACCINATION; ZYGOMYCOSIS;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMMUNICABLE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; GERMANY; HEMATOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MEDICAL ONCOLOGY; OCCUPATIONAL MEDICINE; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TRANSPLANTATION, AUTOLOGOUS;

EID: 84864972425     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1456-8     Document Type: Review

References (86)

1. Bertz H, Auner HW, Weissinger F et al (2003) Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation- guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):S167-S174 (Pubitemid 37265304)
2. Kish MA (2001) Guide to development of practice guidelines. Clin Infect Dis 32(6):851-854 (Pubitemid 32524817)
3. Auner HW, Zebisch A, Ofner P, Sill H, Linkesch W, Krause R (2005) Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases. Ann Hematol 84(8):532-537 (Pubitemid 41001464)
4. Aksu G, Ruhi MZ, Akan H et al (2001) Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 27(2):201-205 (Pubitemid 32156876)
5. Blijlevens NM, Donnelly JP, de Pauw BE (2001) Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect 7(Suppl 4):47-52 (Pubitemid 34966107)
6. Ketterer N, Espinouse D, Chomarat M et al (1999) Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med 106(2):191-197 (Pubitemid 29115960)
7. Weaver CH, Hazelton B, Birch R et al (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86 (10):3961-3969
8. Olivieri A, Offidani M, Montanari M et al (1998) Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 83(4):329-337 (Pubitemid 28217854)
9. Perez-Simon JA, Martin A, Caballero D et al (1999) Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24(12):1279-1283 (Pubitemid 30052782)
10. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ (1996) Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18(2):265-271 (Pubitemid 26283673)
11. Larsson K, Bjorkstrand B, Ljungman P (1998) Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation. Support Care Cancer 6(4):378-383 (Pubitemid 28337129)
12. Scheid C, Draube A, Reiser M et al (1999) Using at least 5×10(6)/ kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation. Bone Marrow Transplant 23(11):1177-1181 (Pubitemid 29259675)
13. Reich G, Cornely OA, Sandherr M et al (2005) Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial. Br J Haematol 130(2):265-270 (Pubitemid 41602527)
14. Gil L, Styczynski J, Komarnicki M (2007) Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 35(6):421-427 (Pubitemid 350307984)
15. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S (2007) Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol 5(5):231-235 (Pubitemid 46860750)
16. Krause R, Auner HW, Gorkiewicz G et al (2004) Detection of catheter-related bloodstream infections by the differential-time-topositivity method and gram stain-acridine orange leukocyte cytospin test in neutropenic patients after hematopoietic stem cell transplantation. J Clin Microbiol 42(10):4835-4837 (Pubitemid 39362417)
17. Child JA, Morgan GJ, Davies FE et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875-1883 (Pubitemid 36532313)
18. Horiuchi T, Gondo H, Miyagawa H et al (2005) Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immunol 6(2):162-166 (Pubitemid 40439543)
19. Bochud PY, Chien JW, Marr KA et al (2008) Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359(17):1766-1777
20. de Boer MG, Jolink H, Halkes CJ et al (2011) Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation. PloS One 6(4):e18403
21. Molle I, Peterslund NA, Thiel S, Steffensen R (2006) MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 38(8):555-560 (Pubitemid 44509548)
22. Mullighan CG, Heatley S, Doherty K et al (2002) Mannosebinding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99(10):3524-3529 (Pubitemid 34534518)
23. Barton T, Collis T, Stadtmauer E, Schuster M (2001) Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 32(3):391-395 (Pubitemid 32173624)
24. Reimer P, Kunzmann V, Wilhelm M et al (2003) Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Hematol 82(5):263-270 (Pubitemid 36701419)
25. Locasciulli A, Bruno B, Alessandrino EP et al (2003) Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant 31(4):295-300 (Pubitemid 36336234)
26. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE (1997) Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 19(2):143-147 (Pubitemid 27068250)
27. Salazar R, Sola C, Maroto P et al (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23(1):27-33 (Pubitemid 29050175)
28. Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091-1100
29. Imataki O, Kami M, Kim SW et al (2004) A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan. Bone Marrow Transplant 33 (12):1173-1179 (Pubitemid 38961473)
30. Molina A, Krishnan AY, Nademanee A et al (2000) High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 89(3):680-689 (Pubitemid 30640116)
31. Krishnan A, Palmer JM, Zaia JA, Tsai NC, Alvarnas J, Forman SJ (2010) HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL). Biol Blood Marrow Transplant 16(9):1302-1308
32. Maertens J, Theunissen K, Verbeken E et al (2004) Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 126(6):852-860 (Pubitemid 39273827)
33. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 186(9):1297-1306 (Pubitemid 35193008)
34. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M (2001) Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97(6):1604-1610 (Pubitemid 32217224)
35. Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y (2004) Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 33(7):745-749 (Pubitemid 38499930)
36. Bavaro MF (2002) Neutropenic enterocolitis. Curr Gastroenterol Rep 4(4):297-301
37. Gomez L, Martino R, Rolston KV (1998) Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clin Infect Dis 27(4):695-699 (Pubitemid 29244319)
38. Gorschluter M, Mey U, Strehl J et al (2005) Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 75(1):1-13 (Pubitemid 40873955)
39. Blot F, Nitenberg G, Chachaty E et al (1999) Diagnosis of catheterrelated bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354 (9184):1071-1077 (Pubitemid 29452819)
40. Gaur AH, Flynn PM, Giannini MA, Shenep JL, Hayden RT (2003) Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 37 (4):469-475 (Pubitemid 37011768)
41. Seifert H, Cornely O, Seggewiss K et al (2003) Bloodstream infection in neutropenic cancer patients related to short-term nontunnelled catheters determined by quantitative blood cultures, differential time to positivity, and molecular epidemiological typing with pulsed-field gel electrophoresis. J Clin Microbiol 41(1):118-123 (Pubitemid 36098564)
42. Ruhnke M, Bohme A, Buchheidt D et al (2012) Diagnosis of invasive fungal infections in hematology and oncology-guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 23(4):823-833
43. Maschmeyer G, Beinert T, Buchheidt D et al (2009) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 45(14):2462-2472
44. Harter C, Schulze B, Goldschmidt H et al (2006) Piperacillin/ tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial. Bone Marrow Transplant 37(4):373-379 (Pubitemid 43250471)
45. Engelhard D, Cordonnier C, Shaw PJ et al (2002) Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 117(2):444-450 (Pubitemid 34451164)
46. Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34(6):730-751 (Pubitemid 34194843)
47. Meisenberg BR, Miller WE, McMillan R et al (1997) Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. J Clin Oncol 15 (1):11-17 (Pubitemid 27020552)
48. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589-1596 (Pubitemid 43810035)
49. Link H, Böhme A, Cornely OA et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society) Ann Hematol 82 (Suppl 2):S105-S117 (Pubitemid 37265297)
50. Ozer H, Armitage JO, Bennett CL et al (2000) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 18(20):3558-3585
51. Auner HW, Sill H, Mulabecirovic A, LinkeschW, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81(7):374-377 (Pubitemid 36067642)
52. Holmberg LA, Boeckh M, Hooper H et al (1999) Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 94(12):4029-4035
53. Kohno K, Nagafuji K, Tsukamoto H et al (2009) Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Transpl Infect Dis 11(4):318-323
54. Lee MY, Chiou TJ, Hsiao LT et al (2008) Rituximab therapy increased post-transplant cytomegalovirus complications in non- Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation. Ann Hematol 87(4):285-289
55. Ng AP, Worth L, Chen L et al (2005) Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. Haematologica 90 (12):1672-1679 (Pubitemid 41814993)
56. Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39 (9):1300-1306 (Pubitemid 39458515)
57. Schiffer JT, Kirby K, Sandmaier B, Storb R, Corey L, Boeckh M (2009) Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Haematologica 94(8):1101-1108
58. Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38(10):1428-1439 (Pubitemid 38678611)
59. Zihlif M, Khanchandani G, Ahmed HP, Soubani AO (2005) Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 78(2):94-99 (Pubitemid 40194099)
60. Cherif H, Martling CR, Hansen J, Kalin M, Bjorkholm M (2007) Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a lifethreatening complication. Support Care Cancer 15(12):1393-1398 (Pubitemid 350077228)
61. Maschmeyer G, Bertschat FL, Moesta KT et al (2003) Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer 39(6):783-792 (Pubitemid 36315995)
62. Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M (2005) Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer 13 (5):332-338 (Pubitemid 40674839)
63. Avery R, Pohlman B, Adal K et al (2000) High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant 25(1):67-69 (Pubitemid 30093158)
64. Arango JI, Restrepo A, Schneider DL et al (2006) Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 37(5):517-521
65. Feld R (1999) Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons. Clin Infect Dis 29(3):503-507 (Pubitemid 29439942)
66. Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D (1996) Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18(2):355-359 (Pubitemid 26283686)
67. Nucci M, Landau M, Silveira F, Spector N, Pulcheri W (2001) Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides. Infect Control Hosp Epidemiol 22(10):651-653 (Pubitemid 33152111)
68. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):427-431
69. Cordonnier C, Chevret S, Legrand M et al (2003) Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 139(1):8-18
70. McQuaker IG, Hunter AE, Pacey S, Haynes AP, Iqbal A, Russell NH (1997) Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 15(2):451-457 (Pubitemid 27074211)
71. Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L (2006) Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol 24(33):5207-5215 (Pubitemid 46631364)
72. Piccirillo N, Sica S, Laurenti L et al (1999) Optimal timing of GCSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation. Bone Marrow Transplant 23 (12):1245-1250 (Pubitemid 29312930)
73. Martino M, Pratico G, Messina G et al (2006) Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients. Eur J Haematol 77(5):410-415 (Pubitemid 44483944)
74. Bucaneve G, Micozzi A, Menichetti F et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353(10):977-987 (Pubitemid 41262332)
75. Micozzi A, Bucaneve G (2005) Prophylaxis and treatment of bacterial infections: do we need new strategies? Rev Clin Exp Hematol 9(2):E4
76. Reuter S, Kern WV, Sigge A et al (2005) Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 40(8):1087-1093 (Pubitemid 40490230)
77. Goodman JL, Winston DJ, Greenfield RA et al (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326(13):845-851
78. Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N (1999) Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis 28(2):331-340
79. Sandherr M, Einsele H, Hebart H et al (2006) Antiviral prophylaxis in patients with haematological malignancies and solid tumours: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 17(7):1051-1059 (Pubitemid 43985238)
80. Ljungman P, Reusser P, de la Camara R et al (2004) Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant 33 (11):1075-1081 (Pubitemid 38786496)
81. Huiqiang H, Qingqing C, Tianxin L et al (2009) Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience. Expert Opin Pharmacother 10(15):2399-2406
82. Ma SY, Lau GK, Cheng VC, Liang R (2003) Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation. Leuk Lymphoma 44(8):1281-1285 (Pubitemid 36764282)
83. Borentain P, Colson P, Coso D et al (2010) Clinical and virological factors associated with hepatitis B virus reactivation in HBsAgnegative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer. J Viral Hepat 17(11):807-815
84. Matsue K, Aoki T, Odawara J et al (2009) High risk of hepatitis Bvirus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients. Eur J Haematol 83(4):357-364
85. Ljungman P, Engelhard D, de la Camara R et al (2005) Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 35(8):737-746 (Pubitemid 40613780)
86. Ljungman P, Nahi H, Linde A (2005) Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 130(1):96-98 (Pubitemid 40979139)